Incidence of macrolide-lincosamide-streptogramin B resistance amongst beta-haemolytic streptococci in the Gambia

被引：4
作者：
Foster-Nyarko E. [1 ]
Kwambana B. [1 ]
Ceesay F. [1 ]
Jawneh K. [1 ]
Darboe S. [2 ]
Mulwa S.N. [1 ]
Ceesay B. [2 ]
Secka O.O. [2 ]
Adetifa I. [3 ,4 ]
Antonio M. [1 ,5 ,6 ]
机构：
[1] Vaccines and Immunity Theme, Medical Research Council Unit the Gambia, Banjul
[2] Clinical Microbiology Department, Medical Research Council Unit the Gambia, Banjul
[3] Disease Control and Elimination Theme, Medical Research Council Unit the Gambia, Banjul
[4] Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London
[5] Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London
[6] Microbiology and Infection Unit, Warwick Medical School, University of Warwick, Coventry
来源：
BMC Research Notes | / 10卷 / 1期
基金：
英国医学研究理事会;
关键词：
Beta-haemolytic streptococci; Gambia; macrolide-lincosamide resistance;
D O I：
10.1186/s13104-017-2427-x
中图分类号：
学科分类号：
摘要：
Background: In West Africa, penicillin, macrolide and lincosamide resistance among beta-haemolytic streptococci (BHS) isolates has rarely been described. However, such data are critical to detect and track the emergence of antibiotic resistance. Methods: Beta-haemolytic streptococci were cultured from clinical specimens from patients attending the clinic at the Medical Research Council Unit The Gambia (n = 217) and kept at -70 °C. Of these, 186 were revived and tested for penicillin susceptibility by disc diffusion and E-test methods, and the D-test for determination of constitutive and inducible macrolide-lincosamide (MLSB) resistance phenotypes. Results: The majority of BHS isolates from infections were group A streptococci (GAS) (126/186, 67.7%). Of these, 16% were from invasive disease (30/186). Other BHS isolated included lancefield groups B (19, 10.2%); C (9/186, 4.8%), D (3/186, 1.6%), F (5/186, 2.7%), G (16/186, 8.6%) and non-typeable (8/186, 4.3%). Prevalence of BHS isolated from blood cultures ranges from 0% (2005) to 0.5% (2010). Most (85, 45.7%) of the isolates were from wound infections. Of the 186 BHS isolates, none was resistant to penicillin and 14 (6.1%) were resistant to erythromycin. Of these, 8 (4.3%) demonstrated constitutive MLSB resistance, and 5 (2.7%) were inducible MLSB resistant. All the inducible MLSB isolates were GAS, and majority of the constitutive MLSB isolates (6/8, 75.0%) were non-GAS. Conclusions: Beta-haemolytic streptococci, predominantly GAS are associated with a wide range of infections in The Gambia. It is reassuring that macrolide and lincosamide resistance is relatively low. However, monitoring of MLSB resistance is necessary with the global spread of resistant BHS strains. © 2017 The Author(s).
引用
收藏
相关论文
共 24 条
  • [1] Antimicrobial Resistance: Global Report on Surveillance, (2014)
  • [2] Prestinaci F., Pezzotti P., Pantosti A., Antimicrobial resistance: A global multifaceted phenomenon, Pathog Glob Health., 109, 7, pp. 309-318, (2015)
  • [3] Sigauque B., Roca A., Mandomando I., Morais L., Quinto L., Sacarlal J., Macete E., Nhamposa T., Machevo S., Aide P., Et al., Community-acquired bacteremia among children admitted to a rural hospital in Mozambique, Pediatr Infect Dis J, 28, 2, pp. 108-113, (2009)
  • [4] Zhu M., Hu Q., Mai J., Lin Z., Analysis of pathogenic bacteria and drug resistance in neonatal purulent meningitis, Zhonghua Er Ke Za Zhi, 53, 1, pp. 51-56, (2015)
  • [5] Chauhan D., Mokta K., Kanga A., Grover N., Singh D., Bhagra S., Group B streptococcal meningitis in children beyond the neonatal period in sub-Himalayan India, Ann Indian Acad Neurol, 18, 1, pp. 71-73, (2015)
  • [6] Broyles L.N., Van Beneden C., Beall B., Facklam R., Shewmaker P.L., Malpiedi P., Daily P., Reingold A., Farley M.M., Population-based study of invasive disease due to β-hemolytic streptococci of groups other than A and B, Clin Infect Dis, 48, 6, pp. 706-712, (2009)
  • [7] Harris P., Siew D.A., Proud M., Buettner P., Norton R., Bacteraemia caused by beta-haemolytic streptococci in North Queensland: Changing trends over a 14-year period, Clin Microbiol Infect, 17, 8, pp. 1216-1222, (2011)
  • [8] Janapatla R.P., Ho Y.R., Yan J.J., Wu H.M., Wu J.J., The prevalence of erythromycin resistance in group B streptococcal isolates at a University Hospital in Taiwan, Microb Drug Resist, 14, 4, pp. 293-297, (2008)
  • [9] Garland S.M., Cottrill E., Markowski L., Pearce C., Clifford V., Ndisang D., Kelly N., Daley A.J., Antimicrobial resistance in group B streptococcus: The Australian experience, J Med Microbiol, 60, pp. 230-235, (2011)
  • [10] Dundar D., Sayan M., Tamer G.S., Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients, Microb Drug Resist, 16, 4, pp. 279-284, (2010)
123